These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32767102)

  • 1. Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment.
    Schelb P; Wang X; Radtke JP; Wiesenfarth M; Kickingereder P; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
    Eur Radiol; 2021 Jan; 31(1):302-313. PubMed ID: 32767102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.
    Schelb P; Kohl S; Radtke JP; Wiesenfarth M; Kickingereder P; Bickelhaupt S; Kuder TA; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
    Radiology; 2019 Dec; 293(3):607-617. PubMed ID: 31592731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully Automatic Deep Learning in Bi-institutional Prostate Magnetic Resonance Imaging: Effects of Cohort Size and Heterogeneity.
    Netzer N; Weißer C; Schelb P; Wang X; Qin X; Görtz M; Schütz V; Radtke JP; Hielscher T; Schwab C; Stenzinger A; Kuder TA; Gnirs R; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
    Invest Radiol; 2021 Dec; 56(12):799-808. PubMed ID: 34049336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a validated prostate MRI deep learning system to independent same-vendor multi-institutional data: demonstration of transferability.
    Netzer N; Eith C; Bethge O; Hielscher T; Schwab C; Stenzinger A; Gnirs R; Schlemmer HP; Maier-Hein KH; Schimmöller L; Bonekamp D
    Eur Radiol; 2023 Nov; 33(11):7463-7476. PubMed ID: 37507610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cascaded Deep Learning-Based Artificial Intelligence Algorithm for Automated Lesion Detection and Classification on Biparametric Prostate Magnetic Resonance Imaging.
    Mehralivand S; Yang D; Harmon SA; Xu D; Xu Z; Roth H; Masoudi S; Sanford TH; Kesani D; Lay NS; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Acad Radiol; 2022 Aug; 29(8):1159-1168. PubMed ID: 34598869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Prostate MRI Lesion Segmentation Agreement Between Multiple Radiologists and a Fully Automatic Deep Learning System.
    Schelb P; Tavakoli AA; Tubtawee T; Hielscher T; Radtke JP; Görtz M; Schütz V; Kuder TA; Schimmöller L; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
    Rofo; 2021 May; 193(5):559-573. PubMed ID: 33212541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.
    Hosseinzadeh M; Saha A; Brand P; Slootweg I; de Rooij M; Huisman H
    Eur Radiol; 2022 Apr; 32(4):2224-2234. PubMed ID: 34786615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of PI-RADS-dependent prostate cancer classification by quantitative image assessment using radiomics or mean ADC.
    Zhang KS; Schelb P; Kohl S; Radtke JP; Wiesenfarth M; Schimmöller L; Kuder TA; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein K; Bonekamp D
    Magn Reson Imaging; 2021 Oct; 82():9-17. PubMed ID: 34147597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
    Sheridan AD; Nath SK; Syed JS; Aneja S; Sprenkle PC; Weinreb JC; Spektor M
    AJR Am J Roentgenol; 2018 Feb; 210(2):347-357. PubMed ID: 29112469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using decision curve analysis to benchmark performance of a magnetic resonance imaging-based deep learning model for prostate cancer risk assessment.
    Deniffel D; Abraham N; Namdar K; Dong X; Salinas E; Milot L; Khalvati F; Haider MA
    Eur Radiol; 2020 Dec; 30(12):6867-6876. PubMed ID: 32591889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms.
    Schrader A; Netzer N; Hielscher T; Görtz M; Zhang KS; Schütz V; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
    Eur Radiol; 2024 Dec; 34(12):7909-7920. PubMed ID: 38955845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.
    Prabhu V; Rosenkrantz AB; Otazo R; Sodickson DK; Kang SK
    J Magn Reson Imaging; 2019 May; 49(5):1400-1408. PubMed ID: 30629317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System.
    Mehralivand S; Bednarova S; Shih JH; Mertan FV; Gaur S; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Urol; 2017 Sep; 198(3):583-590. PubMed ID: 28373133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
    Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
    Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients.
    El-Helaly HA; Mahmoud AA; Magdy AM; Hasehem A; Ibrahim HM; Mohamed KM; Ismail MH
    J Egypt Natl Canc Inst; 2023 Mar; 35(1):5. PubMed ID: 36872409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological to multiparametric MRI spatial mapping of extended systematic sextant and MR/TRUS-fusion-targeted biopsy of the prostate.
    Bonekamp D; Schelb P; Wiesenfarth M; Kuder TA; Deister F; Stenzinger A; Nyarangi-Dix J; Röthke M; Hohenfellner M; Schlemmer HP; Radtke JP
    Eur Radiol; 2019 Apr; 29(4):1820-1830. PubMed ID: 30327861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer.
    Hofbauer SL; Maxeiner A; Kittner B; Heckmann R; Reimann M; Wiemer L; Asbach P; Haas M; Penzkofer T; Stephan C; Friedersdorff F; Fuller F; Miller K; Cash H
    J Urol; 2018 Oct; 200(4):767-773. PubMed ID: 29733838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI.
    Arif M; Schoots IG; Castillo Tovar J; Bangma CH; Krestin GP; Roobol MJ; Niessen W; Veenland JF
    Eur Radiol; 2020 Dec; 30(12):6582-6592. PubMed ID: 32594208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
    Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
    World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation.
    Kan Y; Zhang Q; Hao J; Wang W; Zhuang J; Gao J; Huang H; Liang J; Marra G; Calleris G; Oderda M; Zhao X; Gontero P; Guo H
    Eur Radiol; 2020 Nov; 30(11):6274-6284. PubMed ID: 32524222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.